Skip to main navigation Skip to search Skip to main content

Need for inclusion of high-risk populations and standardisation of immunogenicity outcomes in adult pneumococcal vaccine trials

Zitta Barrella Harboe*, Elisa Cordero, Conor Moran, Laura Kuijpers, Olivier Epaulard, Albert Vollaard

*Corresponding author for this work
Original languageEnglish
JournalThe Lancet Infectious Diseases
Volume25
Issue number7
Pages (from-to)e378-e379
ISSN1473-3099
DOIs
Publication statusPublished - Jul 2025

Cite this